Viewing Study NCT06217393


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-25 @ 11:18 PM
Study NCT ID: NCT06217393
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-29
First Post: 2023-11-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
Sponsor: Abbott
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module